Medical Device News Magazine

UVC PureLight 360​ Proven To Kill The Spread Of COVID-19 Coronavirus

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

UVC PureLight 360​, a new UVC induction light disinfection and sanitization technology, has passed testing that shows the technology kills the indoor spread of numerous pathogens, including COVID-19 Coronavirus.

UVC PureLight 360 Test results from a leading independent international laboratory confirm that the patent-pending 320W UVC Induction/LED prototype from Miami-based UVC PureLight 360 LLC inactivates more than 99.9% of COVID-19 in a 16′ X 16′ room in as little as 3.5 minutes.

COVID-19 has caused more than 1.2 million deaths worldwide in 2020, and the resurgence of the virus in the U.S. has led to more than 10 million current infections.

“UVC light is a proven method to sanitize indoor spaces from many known pathogens, and it’s a critical health advancement to know that our new technology kills the spread of this deadly virus,” said Dr. Minghsun Liu, microbiologist, infectious disease specialist, and UVC PureLight 360TM advisory board member.

The technology also kills germs and bacteria that cause common colds and flu, SARS, MERS, H1N1 and other health threats.

UVC PureLight 360​TM was developed to create safe, clean indoor spaces in a wide variety of locations such as medical facilities, hotels, offices, schools, retail, fitness centers, restaurants and more.

“When launching UVC PureLight 360, we wanted to ensure our device was an effective, tested and proven solution for all these settings,” said Alan Mandel, CEO and co-founder of UVC PureLight 360 LLC. “These verified test results prove our mission to help guests, patients and staff have peace of mind. This is a big step in overcoming the pandemic, as well as the economic hardship it has caused.”

In addition to quickly killing virulent pathogens, the UVC light leaves behind no odors or damaging residues. Currently, most businesses and facilities must spray or wipe down surfaces with harsh chemicals and other antibacterial products to remediate COVID-19.

UVC PureLight 360​TM features a hybrid UVC and LED bulb tower atop a maneuverable cart for easy room-to-room transport. The 320W output is precisely calculated to be effective against a wide range of bacteria and viruses.

The production version of the device is expected to launch in January when health officials fear COVID-19 infections will be surging. While the device is in final development, the company is aligning with distributors across the globe.

“COVID-19 has been an unprecedented public health and economic crisis,” Mandel said. “We’re proud to deliver this solution to businesses, institutions, and the public.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”